Piramal bets on pharma's data binging in $635M buyout

Sold on the growing need for market data in biopharma, India's Piramal Healthcare has scooped up Decision Resources Group in deal valued at about $635 million, Piramal and DRG revealed Wednesday. The deal comes amid rapid business expansion at Decision Resources, which provides web-based research tools, predictive analytics and other services to drugmakers and other healthcare stakeholders. An attracive buyout target, Decision Resources has managed to retain 95% of its customers while serving 48 of the 50 top biopharma companies in the world. Article